All In MedTech

Device Trial Radar · NCT06915363

BioPoly® Partial Resurfacing Knee Implant IDE

Pivotal, Prospective, Randomized, Controlled, Multicenter Clinical Trial of BioPoly® Partial Resurfacing Knee Implant for Treatment of Focal Cartilage Lesions of the Distal Femur

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingTitle says "pivotal". Randomized with 152 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

152

Planned (sponsor's estimate)

Start

Mar 17, 2025

Primary completion

Dec 2028

Study completion Dec 2028

Sponsor

Lead sponsor
BioPoly LLCNot on our public-company list
Sponsor type
Industry
First posted
Apr 8, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 30 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this randomized controlled clinical trial is to demonstrate the safety and effectiveness of the BioPoly® Partial Resurfacing Knee Implant for the treatment of cartilage defects of the distal femur in adult patients with knee pain and symptoms who are candidates for surgical intervention of the knee compared to outcomes for the control group. The primary effectiveness endpoint is Month 24 composite clinical success (CCS) defined by: * no secondary surgical intervention (SSI) and * an improvement from baseline in the Knee injury and Osteoarthritis Outcome Score (KOOS) total score (scaled 0 to 100) of at least 10 points. Researchers will compare the CCS for the investigational device group to a control group receiving the standard of care, either microfracture or debridement). Subjects randomized to the investigational group will receive the BioPoly Knee device and those randomized to the control group will receive the current standard of care, either microfracture or debridement.

Conditions

  • Knee Pain Chronic
  • Knee Osteoarthritis
  • Cartilage Damage
  • Cartilage Defects of the Knee
  • Cartilage or Osteochondral Defects in the Knee
  • Cartilage Lesion

Interventions

  • BioPolyDevice

    partial resurfacing knee replacement

  • surgical standard of care (SSOC)Procedure

    either microfracture or debridement

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Improvement in the Knee injury and Osteoarthritis Outcome Score (KOOS) to Assess Composite Clinical Success (CCS) effectivenessTime frame: 24 months
  2. Composite Clinical Success (CCS) Safety as Measured by No Secondary Surgical IntenventionTime frame: 24 months

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Stanford Medicine Dept of Orthopaedic Surgery

    Redwood City, California · Recruiting

  • Dupont Hospital

    Fort Wayne, Indiana · Recruiting

  • OrthoIndy

    Indianapolis, Indiana · Withdrawn

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.